CVS Homeopathic Childrens’ Remedies Recalled Over Belladonna Poisoning Risk

Several homeopathic kid’s teething and ear relief products sold exclusively at CVS have been recalled, due to concerns that they may contain varying amounts of belladonna, which may be harmful to children. 

The Raritan homeopathic products recall was announced by the FDA on November 24, impacting children’s teething and earache products sold at CVS stores nationwide. The products affected include CVS Homeopathic Infants’ Teething Tablets, Kids Relief Homeopathic Ear Relief Oral Liquid, and CVS Homeopathic Kids’ Ear Relief Liquid.

The recall came after the FDA tested some of the products and found varying levels of belladonna, which differ from the amounts declared on the product labels. Because the amount of belladonna in the products varies, the company decided to issue the recall “out of an abundance of caution.”

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

Belladonna is a plant that is often used for medicinal products, especially homeopathic products. However, in large doses it can be toxic to humans. The varying levels of belladonna detected in the CVS homeopathic products could put children at risk, especially if they contain more than the amount stated on the labels.

The recalled homeopathic products were distributed nationally in CVS stores, including:

  • Kids Relief Homeopathic Ear Relief Oral Liquid 0.85 fl. oz., UPC 778159090639, lot35254.
  • CVS Homeopathic Kids’ Ear Relief Liquid 0.85 fl. oz., UPC 050428441633, lot33149.
  • CVS Homeopathic Infants’ Teething Tablet 135 tablet package, UPC 050428424162, lots 41116 and 43436. CVS had already removed this item from store shelves as of September 30, 2016.

Consumers are advised to stop using the affected products immediately and contact Raritan Pharmaceuticals by phone at 1-866-467-2748. If a child experiences any problems related to taking the product they should visit their doctor immediately.

Adverse events linked to the use of the recalled products should also be reported to the FDA MedWatch Adverse Event program online or by calling 800-FDA-0178.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs.
An Arizona man contends that the manufacturers delayed issuing a recall of sterile water products sold on Amazon, resulting in a serious infection requiring multiple surgeries.